Exploring the Anti-Pulmonary Fibrosis Mechanism of Jingyin Granule by Network Pharmacology Strategy

小桶 颗粒(地质) 系统药理学 计算生物学 肺纤维化 生物 基因 药理学 纤维化 医学 基因本体论 药品 遗传学 基因表达 病理 古生物学 内科学
作者
Dewei Zhu,Qun Yu,Mei‐Fang Jiang,Dandan Wang,Yunhui Shen
出处
期刊:Frontiers in Pharmacology [Frontiers Media SA]
卷期号:13 被引量:5
标识
DOI:10.3389/fphar.2022.825667
摘要

Pulmonary fibrosis (PF) is a clinically common disease caused by many factors, which will lead to lung function decline and even respiratory failure. Jingyin granule has been confirmed to have anti-inflammatory and antiviral effects by former studies, and has been recommended for combating H1N1 influenza A virus (H1N1) infection and Coronavirus disease 2019 (COVID-19) in China. At present, studies have shown that patients with severe COVID-19 infection developed lung fibrotic lesions. Although Jingyin granule can improve symptoms in COVID-19 patients, no study has yet reported whether it can attenuate the process of PF. Here, we explored the underlying mechanism of Jingyin granule against PF by network pharmacology combined with in vitro experimental validation. In the present study, the active ingredients as well as the corresponding action targets of Jingyin granule were firstly collected by TCMSP and literature data, and the disease target genes of PF were retrieved by disease database. Then, the common targets were subjected to Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) enrichment analyses, and then a PPI network and an ingredient-target network were constructed. Next, UPLC-MS was used to isolate and identify selected representative components in Jingyin granule. Finally, LPS was used to induce the A549 cell fibrosis model to verify the anti-PF effect of Jingyin granule in vitro. Our results indicated that STAT3, JUN, RELA, MAPK3, TNF, MAPK1, IL-6, and AKT1 were core targets of action and bound with good affinity to selected components, and Jingyin granule may alleviate PF progression by Janus kinase 2/signal transducers and activators of transcription (JAK2/STAT3), the mammalian nuclear factor-κB (NF-κB), the phosphatidylinositol 3-kinase (PI3K)/protein kinase B (Akt), tumor necrosis factor (TNF), and the extracellular signal-regulated kinases 1 and 2 (ERK1/2) signaling pathways. Overall, these results provide future therapeutic strategies into the mechanism study of Jingyin granule on PF.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
星星完成签到 ,获得积分10
1秒前
欢喜可愁完成签到 ,获得积分10
3秒前
ying818k完成签到 ,获得积分10
4秒前
4秒前
芋头读文献完成签到,获得积分10
4秒前
活着毕业完成签到 ,获得积分10
5秒前
猫小咪完成签到,获得积分10
5秒前
flystone发布了新的文献求助200
6秒前
cttc完成签到,获得积分10
7秒前
谨慎的凝丝完成签到,获得积分10
8秒前
孤独绮梅完成签到 ,获得积分10
8秒前
不做Aspirin完成签到 ,获得积分10
8秒前
10秒前
清秀凡霜完成签到,获得积分10
10秒前
dolabmu完成签到 ,获得积分10
11秒前
Jabowoo完成签到,获得积分10
12秒前
义气访曼完成签到 ,获得积分10
13秒前
有邑义完成签到 ,获得积分10
14秒前
娜娜完成签到 ,获得积分10
14秒前
sen123完成签到,获得积分10
14秒前
Kristine完成签到 ,获得积分10
15秒前
JoJo完成签到,获得积分10
17秒前
zcw完成签到 ,获得积分10
17秒前
宁钦完成签到 ,获得积分10
19秒前
铑氟钌发少年狂完成签到,获得积分10
19秒前
爱吃土豆的小浣熊完成签到,获得积分10
20秒前
vicky完成签到,获得积分10
21秒前
沉吟至今完成签到,获得积分10
21秒前
chen完成签到,获得积分10
22秒前
吕圆圆圆啊完成签到,获得积分10
22秒前
Flynut完成签到,获得积分10
23秒前
dldldldl应助万信心采纳,获得10
24秒前
科研通AI2S应助RJ采纳,获得10
24秒前
xiao6fan完成签到 ,获得积分10
26秒前
Zlinco完成签到,获得积分10
26秒前
shift3310完成签到,获得积分10
26秒前
自觉夏彤完成签到,获得积分10
26秒前
清晨的粥完成签到 ,获得积分10
27秒前
自然怀梦完成签到,获得积分10
28秒前
byyyy完成签到,获得积分10
29秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
Handbook of pharmaceutical excipients, Ninth edition 5000
Aerospace Standards Index - 2026 ASIN2026 3000
Polymorphism and polytypism in crystals 1000
Signals, Systems, and Signal Processing 610
Discrete-Time Signals and Systems 610
T/SNFSOC 0002—2025 独居石精矿碱法冶炼工艺技术标准 600
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 纳米技术 有机化学 物理 生物化学 化学工程 计算机科学 复合材料 内科学 催化作用 光电子学 物理化学 电极 冶金 遗传学 细胞生物学
热门帖子
关注 科研通微信公众号,转发送积分 6043163
求助须知:如何正确求助?哪些是违规求助? 7803575
关于积分的说明 16238186
捐赠科研通 5188699
什么是DOI,文献DOI怎么找? 2776681
邀请新用户注册赠送积分活动 1759736
关于科研通互助平台的介绍 1643256